Literature DB >> 28887206

Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.

Tavarekere N Nagaraja1, Rasha Elmghirbi2, Stephen L Brown3, Lonni R Schultz4, Ian Y Lee5, Kelly A Keenan5, Swayamprava Panda6, Glauber Cabral6, Tom Mikkelsen7, James R Ewing8.   

Abstract

PURPOSE: The objective was to study temporal changes in tumor vascular physiological indices in a period of 24h in a 9L gliosarcoma rat model.
METHODS: Fischer-344 rats (N=14) were orthotopically implanted with 9L cells. At 2weeks post-implantation, they were imaged twice in a 24h interval using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Data-driven model-selection-based analysis was used to segment tumor regions with varying vascular permeability characteristics. The region with the maximum number of estimable parameters of vascular kinetics was chosen for comparison across the two time points. It provided estimates of three parameters for an MR contrast agent (MRCA): i) plasma volume (vp), ii) forward volumetric transfer constant (Ktrans) and interstitial volume fraction (ve, ratio of Ktrans to reverse transfer constant, kep). In addition, MRCA extracellular distribution volume (VD) was estimated in the tumor and its borders, along with tumor blood flow (TBF) and peritumoral MRCA flux. Descriptors of parametric distributions were compared between the two times. Tumor extent was examined by hematoxylin and eosin (H&E) staining. Picrosirus red staining of secreted collagen was performed as an additional index for 9L cells.
RESULTS: Test-retest differences between population summaries for any parameter were not significant (paired t and Wilcoxon signed rank tests). Bland-Altman plots showed no apparent trends between the differences and averages of the test-retest measures for all indices. The intraclass correlation coefficients showed moderate to almost perfect reproducibility for all of the parameters, except vp. H&E staining showed tumor infiltration in parenchyma, perivascular space and white matter tracts. Collagen staining was observed along the outer edges of main tumor mass.
CONCLUSION: The data suggest the relative stability of these MR indices of tumor microenvironment over a 24h duration in this gliosarcoma model.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  DCE-MRI; Glioblastoma; K(trans); Model selection; Test-retest

Mesh:

Substances:

Year:  2017        PMID: 28887206      PMCID: PMC8035668          DOI: 10.1016/j.mri.2017.09.003

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  49 in total

1.  Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.

Authors:  Na Zhang; Lijuan Zhang; Bensheng Qiu; Li Meng; Xiaoyi Wang; Bob L Hou
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

Review 2.  Therapeutic management of gliosarcoma in the temozolomide era.

Authors:  Mary Frances McAleer; Paul D Brown
Journal:  CNS Oncol       Date:  2015-04-23

3.  Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.

Authors:  Audrey Bouchet; Marie Bidart; Imen Miladi; Céline Le Clec'h; Raphaël Serduc; Charles Coutton; Pierrick Regnard; Enam Khalil; Sandrine Dufort; Benjamin Lemasson; Jean Laissue; Laurent Pelletier; Géraldine Le Duc
Journal:  Tumour Biol       Date:  2014-03-16

4.  Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 glioma.

Authors:  Madhava P Aryal; Tavarekere N Nagaraja; Stephen L Brown; Mei Lu; Hassan Bagher-Ebadian; Guangliang Ding; Swayamprava Panda; Kelly Keenan; Glauber Cabral; Tom Mikkelsen; James R Ewing
Journal:  NMR Biomed       Date:  2014-08-14       Impact factor: 4.044

5.  Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.

Authors:  Omprakash Damodaran; Jolandi van Heerden; Anna K Nowak; Michael Bynevelt; Kerrie McDonald; Julie Marsh; Gabriel Lee
Journal:  J Clin Neurosci       Date:  2013-10-30       Impact factor: 1.961

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Authors:  David Cachia; Carlos Kamiya-Matsuoka; Jacob J Mandel; Adriana Olar; Matthew D Cykowski; Terri S Armstrong; Gregory N Fuller; Mark R Gilbert; John F De Groot
Journal:  J Neurooncol       Date:  2015-09-09       Impact factor: 4.130

8.  MRI-Tracked Tumor Vascular Changes in the Hours after Single-Fraction Irradiation.

Authors:  Stephen L Brown; Tavarekere N Nagaraja; Madhava P Aryal; Swayamprava Panda; Glauber Cabral; Kelly Ann Keenan; Rasha Elmghirbi; Tom Mikkelsen; David Hearshen; Robert A Knight; Ning Wen; Jae Ho Kim; James R Ewing
Journal:  Radiat Res       Date:  2015-05-26       Impact factor: 2.841

9.  Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

Authors:  Allison F O'Neill; Lei Qin; Patrick Y Wen; John F de Groot; Annick D Van den Abbeele; Jeffrey T Yap
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

10.  Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI.

Authors:  Xin Li; Wei Huang; Elizabeth A Morris; Luminita A Tudorica; Venkatraman E Seshan; William D Rooney; Ian Tagge; Ya Wang; Jingang Xu; Charles S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-13       Impact factor: 11.205

View more
  1 in total

1.  Imaging acute effects of bevacizumab on tumor vascular kinetics in a preclinical orthotopic model of U251 glioma.

Authors:  Tavarekere N Nagaraja; Rasha Elmghirbi; Stephen L Brown; Julian A Rey; Lonni Schultz; Abir Mukherjee; Glauber Cabral; Swayamprava Panda; Ian Y Lee; Malisa Sarntinoranont; Kelly A Keenan; Robert A Knight; James R Ewing
Journal:  NMR Biomed       Date:  2021-04-04       Impact factor: 4.044

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.